196 related articles for article (PubMed ID: 24996617)
1. HIV-hepatitis C virus co-infection in the era of direct-acting antivirals.
Bichoupan K; Dieterich DT; Martel-Laferrière V
Curr HIV/AIDS Rep; 2014 Sep; 11(3):241-9. PubMed ID: 24996617
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C in HIV-infected patients: impact of direct-acting antivirals.
Bichoupan K; Dieterich DT
Drugs; 2014 Jun; 74(9):951-61. PubMed ID: 24866024
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C and human immunodeficiency virus coinfection in the era of direct-acting antiviral agents: No longer a difficult-to-treat population.
Sikavi C; Chen PH; Lee AD; Saab EG; Choi G; Saab S
Hepatology; 2018 Mar; 67(3):847-857. PubMed ID: 29108121
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of All-Oral Antiviral Regimens in 996 Human Immunodeficiency Virus/Hepatitis C Virus Genotype 1-Coinfected Patients Treated in Routine Practice.
Bhattacharya D; Belperio PS; Shahoumian TA; Loomis TP; Goetz MB; Mole LA; Backus LI
Clin Infect Dis; 2017 Jun; 64(12):1711-1720. PubMed ID: 28199525
[TBL] [Abstract][Full Text] [Related]
5. Are there any challenges left in hepatitis C virus therapy of HIV-infected patients?
Bischoff J; Rockstroh JK
Int J Antimicrob Agents; 2020 Jul; 56(1):105527. PubMed ID: 30145247
[TBL] [Abstract][Full Text] [Related]
6. Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in Canada.
Saeed S; Strumpf EC; Moodie EE; Young J; Nitulescu R; Cox J; Wong A; Walmsely S; Cooper C; Vachon ML; Martel-Laferriere V; Hull M; Conway B; Klein MB;
J Int AIDS Soc; 2017 Nov; 20(3):. PubMed ID: 29116684
[TBL] [Abstract][Full Text] [Related]
7. Direct-Acting Antiretroviral Therapy in Renal Transplant Recipients With Human Immunodeficiency Virus-Hepatitis C Virus Coinfection: Report of Our Experience and Literature Review.
Moreno-Ramirez M; Villanego F; Vigara LA; Cazorla JM; Naranjo J; Garcia T; Merino MJ; Mazuecos A
Transplant Proc; 2020 Mar; 52(2):523-526. PubMed ID: 32035678
[TBL] [Abstract][Full Text] [Related]
8. HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ?
Bruno G; Saracino A; Scudeller L; Fabrizio C; Dell'Acqua R; Milano E; Milella M; Ladisa N; Monno L; Angarano G
Int J Infect Dis; 2017 Sep; 62():64-71. PubMed ID: 28728927
[TBL] [Abstract][Full Text] [Related]
9. Treatment of hepatitis C: the use of the new pangenotypic direct-acting antivirals in "special populations".
Pol S; Parlati L
Liver Int; 2018 Feb; 38 Suppl 1():28-33. PubMed ID: 29427485
[TBL] [Abstract][Full Text] [Related]
10. HIV Coinfected Have Similar SVR Rates as HCV Monoinfected With DAAs: It's Time to End Segregation and Integrate HIV Patients Into HCV Trials.
Shafran SD
Clin Infect Dis; 2015 Oct; 61(7):1127-34. PubMed ID: 26060286
[TBL] [Abstract][Full Text] [Related]
11. Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals.
Rockstroh JK
Liver Int; 2015 Jan; 35 Suppl 1():51-5. PubMed ID: 25529087
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Hepatitis C in HIV-Infected Patients: Moving Towards an Era of All Oral Regimens.
Chen TY; Jain MK
AIDS Patient Care STDS; 2015 Jun; 29(6):329-37. PubMed ID: 26020726
[TBL] [Abstract][Full Text] [Related]
13. Managing HIV/hepatitis C co-infection in the era of direct acting antivirals.
Rockstroh JK; Bhagani S
BMC Med; 2013 Nov; 11():234. PubMed ID: 24228933
[TBL] [Abstract][Full Text] [Related]
14. Real-World Clinical Efficacy and Tolerability of Direct-Acting Antivirals in Hepatitis C Monoinfection Compared to Hepatitis C/Human Immunodeficiency Virus Coinfection in a Community Care Setting.
Gayam V; Hossain MR; Khalid M; Chakaraborty S; Mukhtar O; Dahal S; Mandal AK; Gill A; Garlapati P; Ramakrishnaiah S; Mowyad K; Sherigar J; Mansour M; Mohanty S
Gut Liver; 2018 Nov; 12(6):694-703. PubMed ID: 29938459
[TBL] [Abstract][Full Text] [Related]
15. Treatment of chronic HCV genotype 1 coinfection.
Boesecke C; Rockstroh JK
Curr HIV/AIDS Rep; 2015 Sep; 12(3):326-35. PubMed ID: 26228050
[TBL] [Abstract][Full Text] [Related]
16. Antiviral therapy for HCV in hemophilia A patients with HIV-1 co-infection.
Xiao H; Chen J; Wang J; Li J; Yang F; Lu H
Medicine (Baltimore); 2019 Jul; 98(30):e16524. PubMed ID: 31348267
[TBL] [Abstract][Full Text] [Related]
17. Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"?
Pradat P; Pugliese P; Poizot-Martin I; Valantin MA; Cuzin L; Reynes J; Billaud E; Huleux T; Bani-Sadr F; Rey D; Frésard A; Jacomet C; Duvivier C; Cheret A; Hustache-Mathieu L; Hoen B; Cabié A; Cotte L;
J Infect; 2017 Sep; 75(3):234-241. PubMed ID: 28579302
[TBL] [Abstract][Full Text] [Related]
18. Direct-acting Antivirals for HIV/HCV Co-infected Individuals: As Good as it Gets?
Bruno G; Saracino A
Curr HIV Res; 2017; 15(6):422-433. PubMed ID: 29119934
[TBL] [Abstract][Full Text] [Related]
19. Liver Fibrosis in Human Immunodeficiency Virus (HIV)-Hepatitis C Virus (HCV) Coinfection Before and After Sustained Virologic Response: What Is the Best Noninvasive Marker for Monitoring Regression?
Kronfli N; Young J; Wang S; Cox J; Walmsley S; Hull M; Cooper C; Martel-Laferriere V; Wong A; Pick N; Klein MB;
Clin Infect Dis; 2021 Aug; 73(3):468-477. PubMed ID: 32504083
[TBL] [Abstract][Full Text] [Related]
20. Higher sustained virological response rates at 12 weeks in HIV-HCV co-infection; a tertiary centre experience.
Carvalho L; Pillai S; Daniels E; Sellers P; Whyte R; Eveson L; Foxton M; Nelson M
J Infect; 2020 Feb; 80(2):232-254. PubMed ID: 31734343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]